These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6429989)

  • 1. The effects of dopaminergic blockade on serum TSH and prolactin levels in thyrotoxicosis.
    Swart S; O'Malley BP; Vora J; Barnett DB; Rosenthal FD
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):330-5. PubMed ID: 6429989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of central dopaminergic activity on thyrotropin responsiveness to thyrotropin-releasing hormone in normal and thyrotoxic subjects.
    Röjdmark S
    Horm Metab Res; 1986 Jun; 18(6):407-10. PubMed ID: 3089893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
    Röjdmark S; Carlsson A
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dopaminergic inhibition on serum levels of thyrotrophin and prolactin in patients with hypothyroidism before and after prolonged oral administration of TRH.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):183-8. PubMed ID: 6415988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
    Röjdmark S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin response to metoclopramide in hyperthyroidism.
    Sawers JS; Kellett HA; Brown NS; Seth J; Toft AD
    J Clin Endocrinol Metab; 1982 Jul; 55(1):175-7. PubMed ID: 6804483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women.
    Kauppila A; Ylikorkala O
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):617-23. PubMed ID: 6819904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.
    Eskildsen PC; Kirkegaard CB
    J Endocrinol Invest; 1985 Oct; 8(5):427-31. PubMed ID: 3935709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the dopamin antagonist metoclopramide on the TSH response after oral TRH in the TSH suppression syndrome ("preclinical hyperthyroidism"). Preliminary report].
    Birkhäuser MH; Staub JJ; Gräni R; Girard J; Good E
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1877-9. PubMed ID: 6779375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
    Sowers JR; Carlson HE; Brautbar N; Hershman JM
    J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and thyrotropin responses to thyrotropin-releasing hormone and metoclopramide in men with chronic alcoholism.
    Röjdmark S; Adner N; Andersson DE; Austern J; Lamminpää K
    J Clin Endocrinol Metab; 1984 Oct; 59(4):595-600. PubMed ID: 6434573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and TSH response to TRH and metoclopramide before and after l-thyroxine therapy in subclinical hypothyroidism.
    Lombardi G; Iodice M; Miletto P; Merola B; Panza N; Annunziato L
    Neuroendocrinology; 1986; 43(6):676-8. PubMed ID: 3093910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotic control of the release of prolactin and thyrotropin in euthyroid subjects and patients with pituitary tumors.
    Sowers JR; Hershman JM; Showsky WR; Carlson HE; Park J
    Metabolism; 1977 Feb; 26(2):187-92. PubMed ID: 401926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is normoreninemic essential hypertension caused by disordered central dopaminergic regulation?
    Ogihara T; Maruyama A; Naka T; Higaki J; Kanda T; Goto M; Onishi T; Kumahara Y
    Clin Exp Hypertens (1978); 1980; 2(1):89-97. PubMed ID: 6774864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence for pituitary thyrotroph down-regulation after 1 week of oral thyrotrophin-releasing hormone and metoclopramide under conditions of constant peripheral thyroid hormone levels.
    Grebe SK; Delahunt JW; Feek CM; Purdie G; Porter DJ
    Eur J Endocrinol; 1995 Mar; 132(3):331-7. PubMed ID: 7889183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone responsiveness to metoclopramide in hyperprolactinaemia.
    O'Malley BP; Mercey D; Clarke E; Maguire M; Jackson J; Rosenthal FD
    Clin Sci (Lond); 1987 Mar; 72(3):277-82. PubMed ID: 3816084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.
    Van Thiel DH; Gavaler JS; Sanghvi A
    J Endocrinol Invest; 1982; 5(5):281-6. PubMed ID: 6818270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.